[Reactivation of hepatitis B treated with adefovir after infliximab administration].
Núñez-Rodríguez
María Henar
MH
Santamaría-Martínez
Ana
A
Mata-Román
Laura
L
Caro-Patón
Agustín
A
D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D006509:Hepatitis B / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D063065:Organophosphonates / Q000627:therapeutic use*; D011565:Psoriasis / Q000188:drug therapy*; D012008:Recurrence
D000911:Antibodies, Monoclonal; D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D063065:Organophosphonates; C053001:adefovir; D000069285:Infliximab; D000225:Adenine